Celanese Corporation reported stronger first quarter 2026 results, with improving earnings and cash flow. U.S. GAAP diluted EPS from continuing operations was $0.41 and adjusted EPS was $0.85. Net sales were $2.34 billion, up 6% sequentially, driven mainly by 5% higher volumes.
Engineered Materials delivered $1.3 billion of net sales and operating EBITDA of $324 million, with margins of 25%. The Acetyl Chain generated $1.0 billion of net sales and $194 million of operating EBITDA at a 19% margin. Companywide operating EBITDA reached $455 million.
Free cash flow was modest at $3 million, reflecting seasonal working capital and timing of interest payments, but management raised its full‑year free cash flow outlook to $700–$800 million and targets a net debt to operating EBITDA ratio near 4.8x. The company also outlined Q2 2026 adjusted EPS guidance of $2.00–$2.40 and projected about $3.00 of adjusted EPS in the second half of 2026.
Celanese Corp reports Vanguard Capital Management beneficial ownership of 5,774,130 shares of Common Stock. The filing shows 5.15% of the class and discloses sole dispositive power for 5,774,130 shares and sole voting power for 827,850 shares. The statement attributes holdings to Vanguard Capital Management and several Vanguard affiliates.
Vanguard Portfolio Management reports beneficial ownership of 6,332,554 shares of Celanese Corp common stock, representing 5.65% of the class. The filing states sole voting power of 60,872 shares and sole dispositive power of 6,332,554. The filing notes these holdings include securities held by Vanguard funds and certain affiliates over which Vanguard Portfolio Management exercises dispositive power. Signature block shows the filing was signed on 04/29/2026.
Celanese Corp director Anne P. Noonan has filed an initial Form 3 reporting her beneficial ownership in the company’s common stock. The filing shows she holds 0 shares of Common Stock directly following the reported position as of April 20, 2026.
Celanese Corporation expanded its Board of Directors from nine to 10 members and elected Anne P. Noonan as a director, effective April 20, 2026. She will serve until the 2027 Annual Meeting of Shareholders, when she is expected to stand for election by shareholders.
The Board determined that Ms. Noonan is an independent director under SEC and NYSE standards and is not related to any company officers or directors. A former CEO of Summit Materials and OMNOVA Solutions with more than 30 years of industry experience, she will receive standard non-management director compensation.
Celanese Corporation reported the results of its 2026 Annual Meeting of Shareholders. Nine director nominees were elected to terms expiring at the 2027 annual meeting, each receiving strong support, with votes for individual nominees generally exceeding 91.6 million shares.
Shareholders ratified the selection of KPMG LLP as independent registered public accounting firm for 2026, with 97,496,875 votes for and limited opposition. An advisory vote on executive compensation also passed, receiving 91,098,487 votes for versus 1,766,137 against. Of 111,922,758 shares entitled to vote as of February 23, 2026, 99,090,064 were represented in person or by proxy, reflecting an 88.53% quorum.
Celanese Corp Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned, representing 0% of Common Stock, following an internal realignment. The filing states disaggregated reporting in accordance with SEC Release No. 34-39538 (January 12, 1998). Signed by Ashley Grim on 03/26/2026.
Celanese Corporation and Celanese US Holdings LLC filed a Form S-3 shelf registration on March 25, 2026 to register one or more classes of securities for offering from time to time after the registration statement is declared effective. The prospectus describes common stock, preferred stock, debt securities and guarantees and states that specific terms, aggregate amounts and offering prices will be set forth in prospectus supplements.
The filing identifies certain wholly owned subsidiaries as potential guarantors and discloses authorized capital figures as of February 24, 2026 including 400,000,000 authorized common shares, 170,920,036 issued and 109,571,972 outstanding. The shelf is filed by Celanese as a "well-known seasoned issuer" and permits continuous or delayed offerings under supplemental prospectuses.
Celanese Corp director Kim K.W. Rucker reported a small compensation-related award of phantom stock tied to common shares. On this Form 4, Rucker acquired 5.633 units of phantom stock, each representing the right to receive one share of Celanese common stock. These units reflect dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan. After this award, Rucker holds a total of 9,519.723 phantom stock units, which will be payable in common stock according to the terms of the plan.
Kissire Deborah J. reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Deborah J. Kissire received an automatic award of 3.505 shares of phantom stock tied to deferred compensation dividends. Each phantom stock unit represents the right to receive one share of Celanese common stock under the company’s 2008 Deferred Compensation Plan. Following this grant, she holds a total of 5,924.793 phantom stock units directly, which will eventually be settled in common shares as provided in the plan. This filing reflects routine compensation-related accruals rather than an open-market stock purchase or sale.